NEUROCRINE BIOSCNCE (NB3 BE) stock market data APIs
€112.962
-0.07(-0.1%)
as of March 18, 2026
Try our APIs with
free plan!
NEUROCRINE BIOSCNCE Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for NB3.BE.
Prev. Close
112.962
Open
112.8881
High
113.0643
Low
112.8411
52 wk Range
79.4-134
Market Cap
6 691 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get NEUROCRINE BIOSCNCE data using free add-ons & libraries
Get NEUROCRINE BIOSCNCE Fundamental Data
NEUROCRINE BIOSCNCE Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
NEUROCRINE BIOSCNCE News
New
Is It Time To Reassess Neurocrine Biosciences (NBIX) After Recent Share Price Weakness
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. If you are wondering whether Neurocrine Biosciences is offering good value at its current s...
Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Expectations for Crenessity and Ingrezza
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is among the 7 Most Promising Psychedelic Stocks According to Hedge Funds.Needham Bullish on Neurocrine Biosciences, Inc. (NBIX) Pipeline Amid 2026 Growth Ex...
New Strong Sell Stocks for February 18th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Coinbase Global, Inc. COIN is an operator of crypto platforms. The Zacks Consensus Estimate for its current year earnings ha...
Neurocrine Biosciences Presents Head-to-Head INGREZZA® (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR
INGREZZA showed a nearly two-fold higher VMAT2 occupancy, consistent with greater potency when compared to AUSTEDO XR (deutetrabenazine) after a single dose of each treatment VMAT2 occupancy is a key ...
Get NEUROCRINE BIOSCNCE fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
